Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00021136
DRKS00021136
Recruiting
未知

Evaluation of the diagnostic benefit of contrast-enhanced spectral mammography compared to digital mammography and breast MRI to characterize intraductal breast cancer (DCIS) - ways to avoid over-therapy? - CESM_DCIS

niversitätsklinikum Tübingen0 sites150 target enrollmentMarch 20, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsD05Carcinoma in situ of breast

Overview

Phase
未知
Intervention
Not specified
Conditions
D05
Sponsor
niversitätsklinikum Tübingen
Enrollment
150
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversitätsklinikum Tübingen

Eligibility Criteria

Inclusion Criteria

  • •DCIS proven after punch biopsy
  • •Age \=18 years
  • •written consent from the patient

Exclusion Criteria

  • •patients unable to give their consent
  • •pregnant and breastfeeding patients
  • •contraindication against iodinated contrast medium
  • •contraindication against contrast agent containing gadolinium
  • •implants that are not MR\-compatible and / or metals in / on the body
  • •hearing impairment or increased sensitivity to loud noises
  • •limited sensation of temperature and / or increased sensitivity to body warming
  • •claustrophobia
  • •exclusion criteria according to radiation protection ordinance

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study to evaluate the usefulness of contrast medium 'Sonazoid; Perflubutane' in EUS diagnosis for pancreaticobiliary tumors.pancreaticobiliary neoplastic lesions that require EUS
JPRN-UMIN000020395Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine. Kansai Medical University Hirakata Hospital100
Not yet recruiting
Not Applicable
Evaluation of the clinical value of contrast enhanced ultrasound in the diagnostic and follow-up of renal cell cancerrenal cancerrenal cell carinoma1003836410038430
NL-OMON31004Academisch Medisch Centrum100
Recruiting
Phase 1
Clinical study on the usefulness of contrast ultrasound examination in bile duct diseasepancreasbiliary disease
JPRN-jRCTs041180167Hirooka Yoshiki500
Completed
Not Applicable
Clinical Evaluation of High-resolution, Contrast-enhanced Low-dose Breast-CT (Sub-study I)C50Malignant neoplasm of breast
DRKS00015067Klinik für Diagnostische und Interventionelle Radiologie, Uniklinik RWTH Aachen65
Recruiting
Not Applicable
Comparison of the diagnostic accuracy of Contrast Enhanced Spectral Mammography (CESM) and conventional imaging of Breast Carcinoma.Participants in this study will be adult female who fulfills the following four criteria: 1. Examined by mammography or ultrasound this past year, and was diagnosed as ACR category 3. 2. Diagnosed as CESM applicant by research investigator or sub investigator, having interview, clinical breast examination, and other examinations. 3. Adult female over 20 years old 4. Signed a consent form to participate this clinical study
JPRN-UMIN000004912CESM society60